Loading clinical trials...
Loading clinical trials...
Phase I/II Trial of Autologous Peripheral Blood Progenitor Cell Transplantation With VELCADE Maintenance as Treatment for Intermediate- and Advanced-Stage Multiple Myeloma
Conditions
Interventions
bortezomib
Locations
1
United States
Jonsson Comprehensive Cancer Center at UCLA
Los Angeles, California, United States
Start Date
June 1, 2004
Primary Completion Date
January 1, 2013
Completion Date
January 1, 2013
Last Updated
August 17, 2020
NCT07319897
NCT00305812
NCT00003353
NCT00002878
NCT00726830
NCT00534118
Lead Sponsor
Jonsson Comprehensive Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions